PTIX logo

Protagenic Therapeutics (PTIX) Operating Expenses

Annual Operating Expenses

$4.53 M
+$969.20 K+27.24%

December 31, 2023

Summary

Performance

1-Year Change

+27.24%

3-Year Change

+77.42%

5-Year Change

+95.63%

15-Year Change

+91.39%

PTIX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.32%
PTIX annual total operating expenses is higher than 2.32% of companies in Healthcare sector

High & Low

All-time High

$37.47 M
PTIX annual total operating expenses is currently -87.92% below its historical high of $37.47 million

3-Year Low

$3.56 M
PTIX annual total operating expenses is currently +27.24% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PTIX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 1, 2025
PTIX next annual earnings announcement is scheduled for Apr 1, 2025

OtherPTIXexpensesmetrics:

Annual Total Expenses

$4.53 M
PTIX annual total expenses is $4.53 million

Annual Interest Expense

$107.70 K
PTIX annual interest expense is $107.70 thousand

Annual Income Tax

$0.00
PTIX annual income tax is $0.00

Annual Cost Of Goods Sold

-
PTIX annual cost of goods sold value is unknown

Quarterly Operating Expenses

$652.10 K
-$1.02 M-60.89%

September 30, 2024

Summary

Performance

3-Month Change

-60.89%

1-Year Change

-60.89%

3-Year Change

-60.89%

5-Year Change

-60.89%

PTIX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.26%
PTIX quarterly total operating expenses is higher than 1.26% of companies in Healthcare sector

High & Low

All-time High

$14.64 M
PTIX quarterly total operating expenses is currently -95.54% below its historical high of $14.64 million

3-Year Low

$636.70 K
PTIX quarterly total operating expenses is currently +2.42% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PTIX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
PTIX next earnings announcement is scheduled for Apr 1, 2025

OtherPTIXexpensesmetrics:

Quarterly Total Expenses

$652.10 K
PTIX quarterly total expenses is $652.10 thousand

Quarterly Interest Expense

$0.00
PTIX quarterly interest expense is $0.00

Quarterly Income Tax

$0.00
PTIX quarterly income tax is $0.00

Quarterly Cost Of Goods Sold

-
PTIX quarterly cost of goods sold value is unknown

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$4.53 M
PTIX annual total operating expenses is $4.53 million

Annual SGA

$1.21 M
PTIX annual SGA is $1.21 million

Annual D&A

$28.20 K
PTIX annual depreciation & amortization is $28.20 thousand

PTIX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+27.2%-60.9%
3 y3 years+77.4%-60.9%
5 y5 years+95.6%-60.9%

PTIX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+27.2%-62.5%+2.4%
5 y5-yearat high+117.0%-62.5%+33.4%
alltimeall time-87.9%-100.0%-95.5%+106.6%

Protagenic Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$652.10 K(-60.9%)
Jun 2024
-
$1.67 M(-4.1%)
Mar 2024
-
$1.74 M(+43.4%)
Dec 2023
$4.53 M(+27.2%)
$1.21 M(-15.3%)
Sep 2023
-
$1.43 M(+25.2%)
Jun 2023
-
$1.14 M(+54.7%)
Mar 2023
-
$739.30 K(+12.7%)
Dec 2022
$3.56 M(-14.1%)
$655.80 K(-29.0%)
Sep 2022
-
$924.10 K(+45.1%)
Jun 2022
-
$636.70 K(-52.5%)
Mar 2022
-
$1.34 M(+55.7%)
Dec 2021
$4.14 M(+62.3%)
$861.20 K(+12.7%)
Sep 2021
-
$764.20 K(-41.6%)
Jun 2021
-
$1.31 M(+8.5%)
Mar 2021
-
$1.21 M(+124.7%)
Dec 2020
$2.55 M(+22.3%)
$536.90 K(-50.8%)
Sep 2020
-
$1.09 M(+123.4%)
Jun 2020
-
$488.90 K(-6.1%)
Mar 2020
-
$520.70 K(-29.4%)
Dec 2019
$2.09 M(-9.9%)
$737.20 K(+288.8%)
Sep 2019
-
$189.60 K(-62.5%)
Jun 2019
-
$505.30 K(-22.7%)
Mar 2019
-
$654.00 K(+24.8%)
Dec 2018
$2.31 M(-2.2%)
$524.20 K(+5.2%)
Sep 2018
-
$498.10 K(-27.3%)
Jun 2018
-
$685.10 K(+12.9%)
Mar 2018
-
$606.70 K(-14.4%)
Dec 2017
$2.37 M(+29.3%)
$708.80 K(+34.5%)
Sep 2017
-
$527.00 K(+11.7%)
Jun 2017
-
$471.60 K(-28.3%)
Mar 2017
-
$657.90 K(+18.3%)
Dec 2016
$1.83 M(+272.6%)
$556.30 K(+22.3%)
Sep 2016
-
$454.80 K(-8.4%)
Jun 2016
-
$496.70 K(+54.4%)
Mar 2016
-
$321.60 K(+113.0%)
Dec 2015
-
$151.00 K(+16.2%)
Sep 2015
-
$130.00 K(+14.0%)
Jun 2015
$491.00 K(-49.6%)
$114.00 K(-5.8%)
Mar 2015
-
$121.00 K(-11.7%)
Dec 2014
-
$137.00 K(+16.1%)
Sep 2014
-
$118.00 K(-9.2%)
Jun 2014
$975.00 K(+28.6%)
$130.00 K(-67.3%)
Mar 2014
-
$398.00 K(+64.5%)
Dec 2013
-
$242.00 K(+17.5%)
Sep 2013
-
$206.00 K(-92.9%)
Jun 2013
$758.00 K(-94.9%)
-
Sep 2011
-
$2.92 M(-9.5%)
Jun 2011
-
$3.23 M(+10.7%)
Mar 2011
-
$2.91 M(-3.8%)
Dec 2010
$14.77 M
$3.03 M(-21.5%)
DateAnnualQuarterly
Sep 2010
-
$3.86 M(-7.3%)
Jun 2010
-
$4.16 M(+12.1%)
Mar 2010
-
$3.71 M(-38.3%)
Dec 2009
$26.79 M(-16.0%)
$6.02 M(-5.6%)
Sep 2009
-
$6.38 M(-6.1%)
Jun 2009
-
$6.79 M(-10.8%)
Mar 2009
-
$7.61 M(-283.4%)
Dec 2008
$31.90 M(-14.9%)
-$4.15 M(-142.1%)
Sep 2008
-
$9.85 M(-13.1%)
Jun 2008
-
$11.32 M(-22.6%)
Mar 2008
-
$14.64 M(+6.7%)
Dec 2007
$37.47 M(+125.0%)
$13.71 M(+22.3%)
Sep 2007
-
$11.21 M(+52.3%)
Jun 2007
-
$7.36 M(+41.9%)
Mar 2007
-
$5.19 M(>+9900.0%)
Dec 2006
$16.65 M(>+9900.0%)
-
Oct 2006
-
$14.40 K(-100.1%)
Jul 2006
-
-$9.86 M(-285.1%)
Jul 2006
$71.00 K(-24.9%)
-
Apr 2006
-
$5.33 M(>+9900.0%)
Jan 2006
-
$9700.00(-80.8%)
Oct 2005
-
$50.40 K(-97.1%)
Jul 2005
$94.50 K(>+9900.0%)
-
Jul 2004
$0.00(-100.0%)
-
Apr 2003
-
$1.75 M(+8.8%)
Jan 2003
-
$1.61 M(-9.4%)
Oct 2002
-
$1.77 M(-21.3%)
Jul 2002
$8.55 M(-0.7%)
$2.25 M(+3.5%)
Apr 2002
-
$2.18 M(+2.1%)
Jan 2002
-
$2.13 M(+7.0%)
Oct 2001
-
$1.99 M(-14.2%)
Jul 2001
$8.61 M(+10.8%)
$2.32 M(+8.5%)
Apr 2001
-
$2.14 M(-3.9%)
Jan 2001
-
$2.23 M(+15.7%)
Oct 2000
-
$1.92 M(+284.0%)
Jul 2000
$7.77 M(-3.8%)
$501.00 K(-80.4%)
Apr 2000
-
$2.56 M(+6.5%)
Jan 2000
-
$2.40 M(0.0%)
Oct 1999
-
$2.40 M(+313.8%)
Jul 1999
$8.08 M(+16.3%)
$580.00 K(-78.5%)
Apr 1999
-
$2.70 M(+12.5%)
Jan 1999
-
$2.40 M(0.0%)
Oct 1998
-
$2.40 M(+270.9%)
Jul 1998
$6.95 M(-8.6%)
$647.00 K(-73.0%)
Apr 1998
-
$2.40 M(+20.0%)
Jan 1998
-
$2.00 M(0.0%)
Oct 1997
-
$2.00 M(+17.6%)
Jul 1997
$7.60 M
$1.70 M(-10.5%)
Apr 1997
-
$1.90 M(-9.5%)
Jan 1997
-
$2.10 M

FAQ

  • What is Protagenic Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Protagenic Therapeutics?
  • What is Protagenic Therapeutics annual operating expenses year-on-year change?
  • What is Protagenic Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Protagenic Therapeutics?
  • What is Protagenic Therapeutics quarterly operating expenses year-on-year change?

What is Protagenic Therapeutics annual total operating expenses?

The current annual operating expenses of PTIX is $4.53 M

What is the all time high annual operating expenses for Protagenic Therapeutics?

Protagenic Therapeutics all-time high annual total operating expenses is $37.47 M

What is Protagenic Therapeutics annual operating expenses year-on-year change?

Over the past year, PTIX annual total operating expenses has changed by +$969.20 K (+27.24%)

What is Protagenic Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of PTIX is $652.10 K

What is the all time high quarterly operating expenses for Protagenic Therapeutics?

Protagenic Therapeutics all-time high quarterly total operating expenses is $14.64 M

What is Protagenic Therapeutics quarterly operating expenses year-on-year change?

Over the past year, PTIX quarterly total operating expenses has changed by -$1.02 M (-60.89%)